Clinical and Molecular Characterization of Xia–Gibbs Syndrome: Expanding the Phenotypic Spectrum in a Brazilian Cohort
Authors:
- Maísa Ganz Sanchez SennesMSMaísa Ganz Sanchez Sennes
- Laura Machado Lara CarvalhoLCLaura Machado Lara Carvalho
- Matheus Augusto Araújo CastroMCMatheus Augusto Araújo Castro
- Sofia de Oliveira FariasSFSofia de Oliveira Farias
- Davi Mendes Campo FialhoDFDavi Mendes Campo Fialho
- Eny Maria Goloni BertolloEBEny Maria Goloni Bertollo
- Erika Cristina PavarinoEPErika Cristina Pavarino
- Maria Isabel MelaragnoMMMaria Isabel Melaragno
Open Access
- 11 June 2025
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 108 (6) , 654-663
Abstract
Xia–Gibbs syndrome (XGS) is a rare intellectual disability (ID) syndrome caused by de novo AHDC1 pathogenic variants. We characterized clinical and molecular features of 16 Brazilian patients with XGS. Patient data were collected through semistructured interviews with family members, reanalysis of previous health and genetic assessments, and clinical reports from physicians. Genomic variants and their segregation were validated via Sanger sequencing. Statistical analyses were conducted to evaluate genotype–phenotype associations. Twelve novel AHDC1 causative variants were documented. ID, hypotonia, motor developmental delay, and varied nonspecific facial dysmorphisms were observed in all patients, while speech impairment and autism spectrum disorder were present in nearly all. Three frequent phenotypes, not previously reported, were identified: hyperphagia/food obsession, genital/gonadal alterations in males, and shortening of the Achilles tendon. Additionally, our findings provide statistically significant support for previously reported genotype–phenotype associations between pathogenic variants in the first half of the AHDC1 coding region and the occurrence of epilepsy and scoliosis. We also propose a novel association between N‐terminal variants and developmental regression. In summary, our results broaden the clinical phenotype of XGS, with musculoskeletal and genital/gonadal abnormalities highlighting the multisystem involvement in this condition, beyond neurodevelopmental deficits. Comprehensive phenotypic assessments in all identified XGS cases are recommended to accurately recognize and associate novel clinical signs with XGS.Keywords
All Related Versions
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.110909/2025‐00; 88887.113708/2025‐00)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08028‐1; 2022/03980‐5; 2023/07389‐2; 2023/16666‐0; 2023/16839‐1; 2023/09879‐7)
This publication has 33 references indexed in Scilit:
- A Comprehensive Review of Syndromic Forms of Obesity: Genetic Etiology, Clinical Features and Molecular DiagnosisCurrent Obesity Reports, 2024
- Long read sequencing and expression studies ofAHDC1deletions in Xia‐Gibbs syndrome reveal a novel genetic regulatory mechanismHuman Mutation, 2022
- Genotype–phenotype spectrum and correlations in Xia‐Gibbs syndrome: Report of five novel cases and literature reviewBirth Defects Research, 2022
- Phenotypic and protein localization heterogeneity associated with AHDC1 pathogenic protein‐truncating alleles in Xia–Gibbs syndromeHuman Mutation, 2021
- Clinical presentation and evolution of Xia‐Gibbs syndrome due to p.Gly375ArgfsTer3 variant in a patient from DR Congo (Central Africa)American Journal of Medical Genetics Part A, 2020
- Two Chinese Xia‐Gibbs syndrome patients with partial growth hormone deficiencyMolecular Genetics & Genomic Medicine, 2019
- Variable Clinical Manifestations of Xia‐Gibbs syndrome: Findings of Consecutively Identified Cases at a Single Children's HospitalAmerican Journal of Medical Genetics Part A, 2018
- The phenotypic spectrum of Xia‐Gibbs syndromeAmerican Journal of Medical Genetics Part A, 2018
- De Novo Truncating Mutations in AHDC1 in Individuals with Syndromic Expressive Language Delay, Hypotonia, and Sleep ApneaThe American Journal of Human Genetics, 2014
- Waardenburg syndrome: Clinical differentiation between types I and IIAmerican Journal of Medical Genetics Part A, 2003